Vystar Corporation · OTC:VYST
Vystar — Investor Presentation (January 2010)
17 slides from Vystar's investor presentation, Jan 19, 2010
Slide 1: Created by Nature. Recreated by Science
cq Created by Nature. Recreated by Science JANUARY 2010 vystar
Slide 2: Why Vytex NRL?
(Croatod by Nature. Recreate by Scionea? Proven Raw Material 40,000+ products made with natural rubber latex $2.6B global market Superior performance over synthetics Why Vytex NRL? Latex Allergy Concerns 3%" general population 17% healthcare workers 10% condom users *Source: American Latex Allergy A
Slide 3: Large Global Marketplace ($2.6B)
Created by Nature. Recreated by Science: Large Global Marketplace ($2.6B) Source: International Rubber Study Group, 2006 ™ Gloves | Threads Foams @ Other Dip @ Carpet Adhesives Balloons ~ Condoms l@ Shoes @ Catheters m Other
Slide 4: Vytex NRL Technology
Vytex NRL Technology Vytex technology uses aluminum hydroxide to remove proteins Al(OH); Crystals Generated in Distilled Water ‘Antunes et al. 2002 Mat Chem Phys 76:243-248 Proteins and and reactive surface Al(OH), crystal lutoids bond to the craggy area of Is | A\(OH)3 and impuri centrifugation rem
Slide 5: Vytex NRL Technology
@ ‘Created by Nature. Recreate by Science? Vytex NRL Technology rt = f x 1 rr Field latex containing water Solid Al(OH)3 I Protein-adsorbed Al(OH)3 ‘soluble protein skim layer TA Recovery & Recycling ME Protein = XY AWOH)3 crystal b 4 Protein-adsorbed Al(OH)3 vystar
Slide 6: Vytex: An Adaptive Technology
‘Groatnd by Nature, Rocroated by Science? Vytex: An Adaptive Technology © Latex production —— Malaysia/Thailand — India —— Guatemala
Slide 7: The Accomplishments and Future of Vystar
NX + 5 i , The Accomplishments and Future of Vystar SEC SEC Clearance OTC BB: VYST (August 2009) = FINRA Clearance (September 2009) Reporting Penson Approval (October 2009) Company DTC Clearance (December 2009) R&D Product Expansion (Low Nitrosamine, PV Condom) 4 Reduce COGS Technical Advanced Mater
Slide 8: Organizational Depth: Management Team
cq Crnate by Nature, Recruated by Scie? Organizational Depth Management Tea Extensive sales, marketing and advertising management experience William R. Doyle, President/CEO B2B and B2C Sandra G. Parker, Executive Vice President, Business Successful IPO and Development and Marketing secondary offerin
Slide 9: Board of Directors
cq Crnate by Nature, Recruated by Scie? Board of Directors Broad experience in capital markets William R. Doyle, President/CEO, Chairman of the Board Extensive experience in OTC trading Directors J. Douglas Craft, CEO, Medicraft, Inc. aii deeleaakia ml Joseph C. Allegra, M.D., Founder/Owner, Diamond
Slide 10: Technical and Clinical Advisors
cq ‘Created by Nature. Recruated by Science development Known expertise on natural rubber latex Active management P&L responsi and purchasing influence Noted clinical authors and speakers Technical Catharine C. Calkins-Burke, Ph.D Ranjit K. Matthan, Ph.D, KA Prevulcanised P Ltd. Mark C. Swanson, Qua
Slide 11: Market Pricing Trends
cq Croat by Nature, Recreatd by Sclnce Market Pricing Trends Centrifuged Latex CENTEX’ vs Ribbed Smoked Sheets No. 3 RSS was changed to PSS3 starting September 2006, U.S. CENTS PER TSC POUND - FOB U.S. vystar
Slide 12: Financial Projections
‘Groatnd by Nature, Rocroated by Science? Financial Projections THE FOLLOWING PROJECTIONS ARE FORWARD-LOOKING STATEMENTS. WE MAY NOT ACTUALLY ACHIEVE THE PROJECTIONS DISCLOSED AND YOU SHOULD NOT PLACE UNDUE RELIANCE UPON SUCH FORWARD-LOOKING STATEMENTS. ACTUAL RESULTS COULD DIFFER MATERIALLY FROM SU
Slide 13: 2009 Projections
‘Created by Nature. Recrwated by Science 2009 Projections Vystar Corporation FY 2009 (in 000s) Actual Results Projected at a2 a3 as Total Net Product Sales sou € 4 $6 $32 8 50 Licensing Revenue - 2 2 - _ Total Net Revenue " a 6 32 50 Gross Margin - Product 3 1) J 6 8 Gross Margin - Licensing 7 = a =
Slide 14: 2010 Projections
‘road by Natur, Rocroatd by Sconce Vystar Corporation FY 2010 (in 00's) Net Product Sales Licensing Revenue Total Net Revenue Gross Margin - Product Gross Margin - Licensing Operating expenses Net Income (Loss) Cash Balance, End of Period Sales, in tonnes: Product Sales Licensing Sales 2010 Projecti
Slide 15: 2011 Projections
Vystar Corporation FY 2011 (in 000s) Net Product Sales Licensing Revenue Total Net Revenue Gross Margin - Product Gross Margin - Licensing Operating expenses Net Income (Loss) Cash Balance, End of Period Sales, in tonnes: Product Sales Licensing Sales 2011 Projections Projected Results at a2 a3 a4 T
Slide 16: Vystar Offering
‘Groatnd by Nature, Rocroated by Science? Vystar Offering (Refer to PPM) Total Shares Outstanding Offering Offering Price $2.00 per Share Total: $2,000,000 Up to 1,000,000 Shares of Common Stock Warrants 500,000 at $1.50/share Exercisable within 12 months 500,000 at $3.25/share Exercisable within 24
Slide 17: Why Invest in Vystar?
> Croatnd by Natura, Rocreatd by Sconce Large Global Market 40,000 products made with natural rubber latex $2.6B market Fully Commercialized Why Invest in Vystar? Address Allergenicity Concer Virtually undetectable levels of antigenic protein Endorsed by American Latex Allergy Association Green Foot